RARE

Ultragenyx Pharmaceutical In

-$166.8M

Net Activity

Institutions Holding

293

Popularity Rank

#2029

Avg Weight

0.18%

Total Value

$2.1B

Ownership Trend

293 institutions currently hold RARE, with 175 net buyers and 139 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

139

Net Buying Institutions

175

Key Holders

Key Holders

Top 5 by Value

BI
BlackRock, Inc.
$152.9M
VP
Vanguard Portfolio Management LLC
$112.8M
SS
State Street CORP
$105.2M
AC
Aqr Capital Management LLC
$95.9M
VC
Vanguard Capital Management LLC
$87.8M

Top 5 by Conviction

JH
Jones Hill Capital LP
5.23%
CC
Catalio Capital Management, LP
3.72%
EH
Eagle Health Investments LP
3.24%
SI
Sofinnova Investments, Inc.
2.78%
SF
Sphera Funds Management LTD.
2.69%
View all 293 holding institutions

Quarterly Activity

Recent Activity

+$1.4B

Total Buy Value

$1.2B

Total Sell Value

New buy49
Trim88
Add126
Sold out51

175

Net Buyers

139

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

3

Filings (90d)

$298K

Total Est. Value

10K shares

Planned Shares

Last Filed 2026-07-01
FilerFiling DateEst. Value
HOWARD HORN2026-07-01$156K
Sanders Corazon2026-06-15$50K
Parschauer Karah Herdman2026-06-15$93K

Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker。

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding ULTRAGENYX PHARMACEUTICAL IN (RARE)?
Major stakeholders currently include BlackRock, Inc. ($152.9M), Vanguard Portfolio Management LLC ($112.8M), State Street CORP ($105.2M). Based on the latest 13F filings, there are a total of 293 tracked investment funds and institutions maintaining positions in RARE.
What is the overall institutional sentiment toward RARE recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $166.8M, driven by 175 managers accumulating shares while 139 reduced their exposure.
Which institutions have been selling or reducing their RARE positions?
In the latest period, 88 funds trimmed their holdings, and 51 managers completely exited their positions. The aggregate reported sell value was $1.2B.
Are there any notable investors adding RARE to their portfolios?
Yes, buying activity remains notable. 49 institutions opened new positions in {ticker}, and 126 existing holders added to their shares. The total reported buy value for the quarter amounted to $1.4B.

Related Stocks

Trending Institutional Adds

The most-added stocks by 13F institutions this quarter

MSFT

Microsoft CORP

Institutions Holding

6,150

Total reported value

$2.1T

3245 13F institutions increased their position this quarter

View detail
AMZN

Amazon.com INC

Institutions Holding

5,957

Total reported value

$1.5T

3028 13F institutions increased their position this quarter

View detail
NVDA

Nvidia CORP

Institutions Holding

5,764

Total reported value

$3.0T

2743 13F institutions increased their position this quarter

View detail